Carlos María Galmarini

2PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 20, 2025
PROCC: a predictive score to identify KRAS wild type metastatic colorectal cancer patients who are likely to obtain survival benefit from panitumumab treatment.

Carlos María Galmarini, Rafael Zamora, Pablo Gómez Del Campo

|Jun 23, 2020
Lessons from Hippocrates: Time to Change the Cancer Paradigm.

Carlos M Galmarini

Pageof 1

Frequent Collaborators

1 joint publications

Pablo Gómez Del Campo

1 joint publications

Juan Manuel Domínguez